Traphaco is a renowned pharmaceutical brand in Vietnam, leading the trend in developing drugs based on natural ingredients. With over 50 years of development, Traphaco has the capability to research high-quality drugs and has enhanced the transfer of pharmaceutical technology from advanced countries to create high-quality Vietnamese pharmaceutical products. To date, Traphaco owns 4 GMP-certified manufacturing plants and 7 medicinal herb cultivation regions certified by GACP-WHO.

With the PTBV strategy built on three main pillars: economic development, social responsibility, and environmental protection, Traphaco has successfully implemented a model that connects four key stakeholders: the state (government), farmers, scientists, and businesses. This model leverages diverse resources and knowledge, develops medicinal herb cultivation areas according to international GACP-WHO standards, creates job opportunities, increases the income of medicinal plant growers, and contributes to the preservation and development of Vietnamese medicinal herbs.

Traphaco has been certified as a member of the Ethical Bio Trade (UEBT) alliance and has consistently been recognized among the Top 10 Sustainable Enterprises in Vietnam. It was awarded the Outstanding and Sustainable Asian Enterprise 2022 (Community Initiative Category) and ranked among the Top 50 Best Listed Companies in Vietnam by Forbes.

Mr. Nguy Quoc Anh has been with Traphaco for 10 years, responsible for planning and executing corporate brand and product communication activities; organizing the company's PR and CSR events; and serving as an internal lecturer on brand and product training.